Weekly Top Insider Buys Highlight for the Week of April 27

The largest Insider Buys this week were for Philip Morris International Inc., Biogen Inc., GrafTech International Ltd. and H.B. Fuller Co.

Author's Avatar
Apr 28, 2018
Article's Main Image

The largest Insider Buys this week were for Philip Morris International Inc. (PM, Financial), Biogen Inc. (BIIB, Financial), GrafTech International Ltd. (EAF, Financial) and H.B. Fuller Co. (FUL, Financial).

Philip Morris International Inc. (PM, Financial): Deputy Gen. Counsel and Corporate Secretary Jerry Whitson bought 3,000 shares

Deputy Gen. Counsel and Corporate Secretary Jerry Whitson bought 3,000 shares of PM stock on April 25 at the average price of $82.76. The price of the stock has decreased by 0.24% since.

Philip Morris International Inc. is an American international cigarette and tobacco manufacturing company best known for its Marlboro brand. The company has sold products in over 180 countries and is a component of the S&P 100. The company has a market capitalization of $128.34 billion, and as of April 27 it traded at $82.56.

On April 19 Philip Morris International Inc. reported first quarter 2018 results. Reported diluted earnings for the quarter was $1.00, down by 2% compared to the same quarter of 2017. Operating income increased by 0.4% for the quarter to $2.4 billion compared to the same quarter of 2017. Net revenues increased by 13.7%, to $6.9 billion from the same quarter last year.

Biogen Inc. (BIIB, Financial): Director Alexander J. Denner bought 48,000 shares

Director Alexander J. Denner bought 48,000 shares of BIIB stock on April 25 at the average price of $269.91. The price of the stock has increased by 2.55% since.

Biogen Inc. is an American international biotechnology company specializing in the research, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases. Some of the products of the company include Alprolix, Avonex, Eloctate, Fampyra, and Gazyva. The company has a market capitalization of $58.41 billion, and as of April 27 it traded at $276.80.

On April 24 Biogen Inc. reported first quarter 2018 financial results. Total revenues were $3.1 billion, an 11% increase versus the prior year. GAAP net income was $1.2 billion, compared to $748 million during the same quarter of 2017. Diluted earnings per share were $5.54, compared to $3.46 during the same quarter prior year.

GrafTech International Ltd. (EAF, Financial): Director Brian L. Acton bought 5,000 shares

Director Brian L. Acton bought 5,000 shares of EAF stock on April 23 at the average price of $15. The price of the stock has increased by 8.4% since.

GrafTech International Ltd. is an American material sciences company that chiefly manufactures carbon and graphite products. The company is wholly owned by Brookfield Asset Management. Some of its key products include synthetic graphite and carbon electrodes. The company has a market capitalization of $4.91 billion, and as of April 27 it traded at $16.26.

On April 23 GrafTech International Ltd. announced the closing of its initial public offering of 35 million shares of its common stock. The shares were sold by its sole stockholder, an affiliate of Brookfield Business partners LP, at a price to the public of $15 per share. The seller has granted the underwriters a 30-day overallotment option of up to an additional 5.25 million shares of common stock.

H.B. Fuller Co. (FUL, Financial): Executive VP and CFO John J. Corkrean bought 9,600 shares

Executive VP and CFO John J. Corkrean bought 9,600 shares of FUL stock on April 23 at the average price of $52.06. The price of the stock has decreased by 3.02% since.

H.B. Fuller Co. is an American international adhesives manufacturing company. The company is well known for its careful handling of toxic waste and the nature reserve built around its headquarters. The company has a market capitalization of $2.55 billion, and as of April 27 it traded at $50.49.

On March 28 H.B. Fuller Co. reported financial results for the first quarter of 2018 that ended on March 3. Net revenue increased by 42% during the quarter compared to the first quarter of 2017. Net income was $47.7 million, while adjusted net income was $18.4 million. Earnings per diluted share were 35 cents.

For the complete list of stocks that were bought by their company executives, go to: Insider Trades.

Disclosure: I do not own stock in any of the companies mentioned in the article.